Document |
Document Title |
WO/1996/039693A1 |
A digital information recording media which includes a recording layer comprising a light-stable colored composition which composition is mutable or decolorizable upon exposure to a specific wavelength of ultraviolet radiation. The light...
|
WO/1996/038150A1 |
The present invention relates to novel 4.4-(disubstituted)cyclohexan-1-ols monomers and related compounds, pharmaceutical compositions containing these compounds, and their use in treating allergic and inflammatory diseases and for inhib...
|
WO/1996/038400A1 |
A method for preparing a meta-dihydroxylated aromatic compound, and more particularly for preparing resorcin or 1,3-diphenol is described. The preparation of a meta-dihydroxylated aromatic acid as an intermediate is also described. The m...
|
WO/1996/037454A1 |
The object of the invention is a method for preparing 3-carboxy-4-hydroxybenzaldehydes and derivatives thereof from phenol compounds bearing formyl and/or hydroxymethyl groups in positions 2 and 4. Another object of the invention is the ...
|
WO/1996/034851A1 |
The present invention provides a compound of formula (I), (II), (III) or (IV), processes for the preparation of the compounds of the invention, intermediates useful in these processes, a pharmaceutical composition, and methods of using t...
|
WO/1996/032366A1 |
Naphthol derivatives represented by general formula (I), wherein Y and Y' represent each -(CONH)n-X or -COR; X represents phenyl, naphthyl, anthraquinonyl, benzimidazolonyl or carbazolyl; R represents hydroxy, C1-6 alkoxy, halogeno, benz...
|
WO/1996/030329A1 |
The invention relates to substituted benzenes and derivatives thereof, useful as neuraminidase inhibitors, to pharmaceutical compositions comprising such compounds, and to methods of using these compounds for treating viral and other inf...
|
WO/1996/028403A1 |
Tetracyclic compounds having structure (1) are described, wherein R1-R10 are as defined. The tetracyclic compounds are capable of potent effects on steroid sensitive tissues and have demonstrated increased uterine weight, antiovolatory e...
|
WO/1996/026176A1 |
A method for carboxylating a phenol ether, particularly guaiacol and guetol, wherein said phenol ether in salt form is reacted with carbon dioxide at a temperature below 150 �C in an aprotic, polar and basic organic solvent.
|
WO/1996/026175A1 |
A method for preparing a 4-hydroxybenzaldehyde having at least one substituent in the ortho position of the OH group, is disclosed. In particular, the preparation of 3-methoxy-4-hydroxybenzaldehyde and 3-ethoxy-4-hydroxybenzaldehyde is d...
|
WO/1996/025383A1 |
Novel benzoic acid derivatives have formula (I) wherein: -X- represents C1 to C6 alkylene, C2 to C6 alkenylene or a divalent moiety having the structure -(CH2)m-Z- in which m is an integer from 0 to 3 and Z represents -O-, -S- or -NH-; -...
|
WO/1996/022335A1 |
A light-stable colored composition which includes a colorant and a radiation transorber. The colorant, in the presence of the radiation transorber, is adapted, upon exposure of the transorber to specific, narrow bandwidth radiation, to b...
|
WO/1996/020930A1 |
Acetylenes substituted with a phenyl or heteroaryl group and with a 5,6,7,8-tetrahydronaphthyl or 7,8-dihydronaphthyl group have retinoid-like biological activity. The 5,6,7,8-tetrahydronaphthyl or 7,8-dihydronaphthyl group is substitute...
|
WO/1996/020937A1 |
Compounds of formula (1), wherein R1-R3 and R5 independently are hydrogen, lower alkyl of 1 to 6 carbons, branched chain alkyl or cycloalkyl of 3 to 15 carbons, lower alkyl substituted cycloalkyl of 3 to 15 carbons; R4 is lower alkyl of ...
|
WO/1996/019995A1 |
This invention relates to derivatives of 4,4-(disubstituted)cyclohexan-1-ones and related compounds which are useful for treating allergic and inflammatory diseases.
|
WO/1996/019988A1 |
The present invention relates to novel 4,4-(disubstituted)cyclohexan-1-ols monomers and related compounds, pharmaceutical compositions containing these compounds, and their use in treating allergic and inflammatory diseases and for inhib...
|
WO/1996/020436A1 |
A toner resin composition comprising a toner resin and the metal salt or complex of a carbocyclic hydroxy carboxylic acid containing at least one methylene group optionally substituted by hydroxy or amino such as 4-(N-methyl-N-2-hydroxye...
|
WO/1996/020158A1 |
This invention relates to derivatives of 3,3-(disubstituted)cyclohexan-1-one monomers and related compounds which are useful for treating allergic and inflammatory diseases.
|
WO/1996/019776A1 |
A data processing form for use with photo-sensing apparatus that detect the presence of indicia at indicia-receiving locations on the form. The form is composed of a sheet of carrier material and plurality of indicia-receiving locations....
|
WO/1996/019502A1 |
A colored composition which includes a mutable colorant, an ultraviolet radiation transorber, and a molecular includant, wherein more than two molecules of the ultraviolet radiation transorber are covalently coupled to each molecule of t...
|
WO/1996/015096A1 |
Inhibitors for matrix metalloproteases, pharmaceutical compositions containing them, and a process for using them to treat a variety of physiological conditions. The compounds of the invention have the generalized formula (T)xA-B-D-E-G, ...
|
WO/1996/011902A1 |
The present invention relates to compounds of formula (I), wherein: A, B and D are various ring systems as defined in the description, R1 is one of a variety of groups as defined in the description, R3 is hydrogen or C1-4 alkyl and Z is ...
|
WO/1996/011920A1 |
This invention relates to novel benzopyran and other benzo-fused leukotriene B4 (LTB4) antagonists of formula (I), and the pharmaceutically acceptable salts thereof, wherein A1 is O, CH2, S, NH or N(C1-C6)alkyl; R3 is hydrogen or hydroxy...
|
WO/1996/006822A1 |
The present invention relates to compounds of formula (I) wherein: A is an optionally substituted ring system as defined herein; B is an optionally substituted 5- or 6-membered heteroaryl ring system or optionally substituted phenyl; D i...
|
WO/1996/006604A2 |
This invention provides a method of identifying and reversing multidrug resistance in a multidrug resistance tumor comprising administering a multidrug resistance reversing amount of any of the compounds as defined herein.
|
WO/1996/004905A1 |
Phenoxyphenylacetic acids and derivatives of general structural formula (I) have endothelin antagonist activity and are useful in treating cardiovascular disorders, such as hypertension, postischemic renal failure, vasospasm, cerebral an...
|
WO/1996/003418A1 |
The present invention relates to novel soluble combinatorial libraries, comprising a soluble phase in solution attached to a core molecule, and allowing the improved high-yield and efficient production of soluble combinatorial libraries....
|
WO/1996/002486A1 |
The present invention relates to novel 4-halo-2-fluoro-5-alkylbenzoyl compounds and their methods of manufacture. These compounds are useful for the preparation of agricultural chemicals and medicines, particularly as intermediates for a...
|
WO/1996/002515A1 |
The disclosure herein relates to the title compounds of formula (I) and salts and esters thereof, wherein X is halogen, C1-6 polyhaloalkyl, C6-10 aryloxy, C1-6 alkoxy or alkylsulfonyl, C4-10 tert-alkyl, NO2 or CN; n is 0-4 and Z is an (u...
|
WO/1996/000788A1 |
Transgenic plants with at least one heterologous DNA sequence have an increased secondary substance content. Also disclosed is a process for producing the same and their use in forestry, grazing lands, meadows, ornamental and useful plan...
|
WO/1996/000271A1 |
The invention concerns the use of 'beta'-dicarbonyl or aromatic ortho-hydroxycarbonyl compounds to mark hydrocarbons, as well as hydrocarbons containing 'beta'-dicarbonyl or aromatic ortho-hydroxycarbonyl compounds as markers and a metho...
|
WO/1995/029171A1 |
A method for making arthropodicidal oxadiazines and intermediates which are racemic or enantiomerically enriched at their chiral center, the method for making the oxadiazines comprising reaction of an intermediate selected from (II) or (...
|
WO/1995/027692A1 |
Novel compounds for formula (I) are described herein. These compounds inhibit the production of Tumor Necrosis Factor and are useful in the treatment of disease states mediated or exacerbated by TNF production; these compounds are also u...
|
WO/1995/024380A1 |
A compound for controlling Take-all disease of plants by applying, preferably to the seed prior to planting, a fungicide of formula (I) wherein R2 is ethyl, iso-propyl, propyl or allyl; A is N(CH3)1-nHnR5 or OR6 wherein n is 0 or 1, R5 i...
|
WO/1995/022546A1 |
Therapeutic compounds with at least one carboxylic, acid, ester or amide-substituted moiety have the formula: TERMINAL MOIETY-(R)j. In the formula, j is an integer from one to three, the terminal moiety is an aliphatic chemical moiety or...
|
WO/1995/022520A1 |
A compound of structure (I), wherein, when R8 = H: R1 = alkyl, cycloalkyl, arylalkyl, aryl; R2 = cycloalkyl, aryl, C3-C10 alkyl; X, Y = O, S(O)n, NH; Z = CH2OH, NHSO2R3, CHO, CO2R3, CONHR4R5, CN, COR6, H, halo, NHCN, NHCONR4R5, CONR4OR5,...
|
WO/1995/020034A1 |
The aim is to discover effective builders for washing or cleaning agents which not only prevent or reduce the formation of incrustations but also exhibit polyfunctional, or at least bifunctional effects important to washing or cleaning a...
|
WO/1995/018088A1 |
A benzoic acid derivative represented by general formula (I) and a salt thereof wherein R1 and R2 may be the same or different from each other and each represents hydrogen or C1-C5 alkyl. The compound is superior to the conventional ones...
|
WO/1995/017484A1 |
A fuel additive having formula (I), where A1 is a thioether, a sulfoxide, a sulfone, a sulfonic acid, a sulfonamide, a nitrile, a carboxylic acid or ester, or a carboxamide; R1 and R2 are independently hydrogen, hydroxy, lower alkyl, or ...
|
WO/1995/017183A1 |
This invention provides methods for the treatment or prevention of Alzheimer's disease in a mammal which comprises administering to a mammal in need thereof an effective amount of an inhibitor of phospholipase A2. This invention also pro...
|
WO/1995/015752A1 |
This invention relates to a compound of formula (I), where the several groups are defined herein. These compounds are leukotriene antagonists and as such can be used in treating various diseases associated with leukotrienes.
|
WO/1995/015304A1 |
This invention relates to naphthalene dicarboxylic acids or naphthalene dicarboxylic esters substituted with aroyl groups. More particularly, this invention relates to the following compounds: dialkyl 1-benzoyl-2,6-naphthalene dicarboxyl...
|
WO/1995/013262A1 |
Compounds of formula (I) are described wherein R1 is hydrogen, -(lower alkyl)q(CO2R6 or OH), -CN, -C(R7)=NOR8, NO2, -O(lower alkyl)R9, -CC-R10, -CR11=C(R12)(R13), -C(=O)CH2C(=O)CO2H, -CO(R14), alkylthio, alkylsulphinyl, alkylsulphonyl, c...
|
WO/1995/013059A1 |
Novel farnesyl derivatives which are inhibitors of the prenylated protein methyltransferase enzyme, and useful as anti-cancer drugs, have formula (I), wherein R1 represents farnesyl, geranyl or geranyl-geranyl; Z represents C-R2 or N; R2...
|
WO/1995/011242A1 |
Compounds of formula (I), wherein m is 1-4; R1-R4 independently are hydrogen, lower alkyl of 1 to 6 carbons, Cl, Br, or I; R5 is hydrogen, lower alkyl of 1 to 6 carbons, Cl, Br, I, lower alkoxy or lower thioalkoxy of 1-6 carbons; R6 is h...
|
WO/1995/010504A1 |
Compounds of formula (I), wherein R1 represents C1-4alkyl; R2 represents hydrogen, halogen, C1-4alkyl, C1-4alkoxy, C1-4alkoxyC1-4alkyl, C1-4alkylsulphonyl, trifluoromethylsulphonyl; optionally substituted arylsulphonyl, optionally substi...
|
WO/1995/005805A1 |
The present invention relates to a process for providing a stable crystallinic form to a fine-grained substance or a substance mixture, which can be produced, stored and used while maintaining the aerodynamic properties required for inha...
|
WO/1995/004955A1 |
A colored composition which includes a colorant and an ultraviolet radiation transorber. The colorant, in the presence of the ultraviolet radiation transorber, is adapted, upon exposure of the transorber to ultraviolet radiation, to be m...
|
WO/1995/004036A1 |
Compounds, compositions, and methods for modulating processes mediated by Retinoid X Receptors using retinoid-like compounds which have activity selective for members of the subclass of Retinoid X Receptors (RXRs), in preference to membe...
|
WO/1995/004277A1 |
Methods for rapidly generating large rationally designed libraries of structurally-diverse small molecular weight compounds using a multicombinatorial approach. Also disclosed are compounds of formula (I).
|